FzioMed Inc. Granted Patent Expanding Biomaterial Technology in the Field of Aesthetic Medicine, Soft Tissue Augmentation

SAN LUIS OBISPO, Calif.--(BUSINESS WIRE)--FzioMed, Inc. announced today the issuance of United States patent 7,192,984 B2 which broadens coverage for the company’s proprietary biomaterial technology in the field of aesthetic medicine.
MORE ON THIS TOPIC